Spyre Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Spyre Therapeutics, Inc. - overview
Established
2023
Location
Waltham, MA, US
Primary Industry
Biotechnology
About
Based in San Francisco, US, and founded in 2023, Spyre Therapeutics, Inc. operates as a biotechnology research firm that develops antibody therapies for the treatment of inflammatory bowel disease (IBD). In June 2023, Aeglea BioTherapeutics, Inc. , a portfolio company of OrbiMed Advisors and Rock Springs Capital, acquired Spyre Therapeutics.
The firm focuses on developing optimized treatments for inflammatory bowel disease by creating antibody-rational therapeutic combinations and employing precision immunology approaches. Their goal is to enhance treatment efficacy, safety, and convenience for patients.
Current Investors
Adage Capital Management, RTW Investments, Farallon Capital Management
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.spyre.com
Verticals
HealthTech
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
Spyre Therapeutics, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PIPE | Completed | Spyre Therapeutics, Inc. | - |
Displaying 1 - 1 of 1
Spyre Therapeutics, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.